Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A in Traumatic Brain Injury
NCT02496975Phase 2Withdrawn
- Start
- Aug 2017
- Primary completion
- Aug 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in traumatic brain injury (TBI). Planned start Aug 2017; status: withdrawn.
02
Drugs
cyclosporine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02496975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496975.